BOSTON and LONDON, Sept. 3, 2025 /PRNewswire/ -- Ampersand Capital Partners ("Ampersand"), a global private equity firm specializing in life sciences and healthcare growth investments, today announced the opening of a new office in London. The move further strengthens the firm's European footprint, building on the success of its Amsterdam office launched in 2017.
As part of this expansion, Ampersand announced that Matthew Norton has joined the firm as a General Partner based in London, where he will lead its European efforts. Matt brings more than 15 years of healthcare private equity experience, most recently serving as a Partner at Cinven. In that role, he helped shape the firm's healthcare strategy and led transformative growth initiatives across Europe and the United States.
In addition, Marina Pellon-Consunji. Partner will be relocating to London. Marina was instrumental in establishing Ampersand's Amsterdam presence, leading multiple platform investments and add-on acquisitions across Europe. She will continue to drive these efforts from the new London office.
"We are pleased to announce the addition of Matthew Norton to Ampersand's team, along with the opening of a London office," said Herb Hooper, Managing Partner of Ampersand. "With Matt's and Marina's experience and leadership, we are well-positioned to continue identifying and scaling the next generation of global healthcare and life sciences companies."
The new London office underscores Ampersand Capital Partners' long-term commitment to building exceptional growth-stage companies worldwide. For more than 30 years, Ampersand has focused on building market-leading companies in the life sciences and healthcare sectors, by accelerating growth across lab products, lab services, contract manufacturing, pharma services, and specialty products companies. Together with its established offices in Boston and Amsterdam, the London presence positions Ampersand as a global leader in healthcare and life sciences private equity.
About Ampersand Capital Partners
Ampersand Capital Partners, founded in 1988, is a middle-market private equity firm with $3 billion of assets under management, dedicated to growth-oriented investments in the healthcare sector. With hubs in Boston, Amsterdam, and London, Ampersand leverages a unique blend of private equity and operating experience to build value and drive long-term performance alongside its portfolio company management teams. Ampersand has helped build numerous market-leading companies across each of the firm's core healthcare sectors. For additional information, visit www.ampersandcapital.com or follow us on LinkedIn.
SOURCE Ampersand Capital Partners
Share this article